March 13, 2026 · Form 4 insider transaction
Anderson Karen M. sold 107,961 shares of CENTESSA PHARMACEUTICALS PLC at $26.15 per share, a transaction worth $2.82M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.; The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.75 to $26.705, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.